NSABP B-43: A phase III clinical trial to compare trastuzumab (T) given concurrently with radiation therapy (RT) to RT alone for women with HER2+ DCIS resected by lumpectomy (Lx).
Melody A. Cobleigh
Consultant or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche
Stewart J. Anderson
No relevant relationships to disclose
Thomas B. Julian
No relevant relationships to disclose
Kalliopi P. Siziopikou
No relevant relationships to disclose
Douglas W. Arthur
No relevant relationships to disclose
Rachel Rabinovitch
No relevant relationships to disclose
Ping Zheng
No relevant relationships to disclose
Eleftherios P. Mamounas
Consultant or Advisory Role - Roche
Norman Wolmark
No relevant relationships to disclose